Across TCGA pan-cancer cohorts, MIR1303 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR1303’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR1303 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR1303 is over-expressed in tumor, although a few such as THCA and COAD show the opposite, repressed pattern.

STAD, THCA, and COAD are the cancer types where MIR1303 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR1303 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	+0.342	.035	2	view →
THCA	Female	II,III,IV	−0.323	.016	2	view →
COAD	Female	All	−0.175	.016	2	view →
KIRC	All	IV	−0.147	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR1303 RNA expression & survival · all MIR1303 data types